期刊文献+

胰岛素抵抗与子宫内膜癌发生的关系研究 被引量:5

Association between insulin resistance and endometrial carcinoma
下载PDF
导出
摘要 目的探讨胰岛素抵抗与子宫内膜癌发生的关系。方法收集68例子宫内膜癌(EC)患者及68例健康对照者标本,分别对其空腹血糖(FG)、空腹胰岛素水平(FIN)进行检测,对两组病例FG、FIN、胰岛素敏感指数(ISI)及体质指数(BMI)进行比较,分析胰岛素抵抗(IR)与EC患者生育特征的关系。结果两组FG、FIN、BMI及ISI差异均有统计学意义(t分别=2.86、-9.31、10.16、11.09,P均<0.05)。EC组IR阳性率(60.02%),显著高于对照组(17.65%)。EC患者IR的发生与BMI、有无生育史及排卵障碍相关(χ2分别=5.43、5.12,P均<0.05)。结论对代谢指征的良好控制可能为今后提高子宫内膜癌预后的研究提供新的方向。 Objective To evaluate the association between insulin resistance (IR) and endometrial carcinoma (EC). Methods Sixty eight EC patients and 68 healthy patients were enrolled in this study. Fasting serum was analyzed for glucose and insulin. Fasting glucose (FG), fasting insulin (FIN), insulin sensitive index (ISI) and body mass index (BMI) were analyzed and compared between EC and healthy control group. Association between IR and reproductive and menstrual characteristics were evaluated. Results Compared with the control group,FG,FIN,ISI and BMI for EC group were significantly different (t=2.86,-9.31,10.16, 11.09,P〈0.05). The prevalence of IR was much higher in EC group(60.02%) than that of the normal people (17.65%). The presence of IR in EC patients was associated with BMI,nulliparity and chronic anovulation (X2=5.43,5.12,P〈0.05). Conclusions Control of metabolic parameters may provide a promising way to improve EC prognosis.
出处 《全科医学临床与教育》 2012年第3期274-276,共3页 Clinical Education of General Practice
关键词 子宫内膜癌 胰岛素抵抗 体质指数 endometrial carcinoma insulin resistance body mass index
  • 相关文献

参考文献11

  • 1Rosato V,Zucchetto A,Bosetti C,et al.Metabolic syndrome and endometrial cancer risk [J]. Ann 0ncol,2011,22 (4): 884-889.
  • 2McTiernan A,Irwin M,Vongruenigen V.Weight,physical ac- tivity,diet,and prognosis in breast and gynecologic cancers[J]. J Clin Oncol,2010,28(26):4074-4080.
  • 3Lucenteforte E, Bosetti C,Talamini R, et al. Diabetes and e- ndometrial cancer: effect modification by body weight, phys- ical activity and hypertension[J]. Br J Cancer,2007,97(7): 995-998.
  • 4Friedenreich CM, Biel RK,Lau DC,et al. Case-control stu-dy of the metabolic syndrome and metabolic risk factors for endometrial cancer[J]. Cancer Epidemiol Biomarkers Prev, 2011,20( 11 ) : 2384-2395.
  • 5Zhang G, Li X, Zhang L, Zhao L, et al. The expression and role of hybrid insulin/insulin-like growth factor receptor ty- pe 1 in endometrial carcinoma cells[J]. Cancer Genet Cyto- genet, 2010,200(2) : 140-148.
  • 6McGrath M, Lee IM, Buring J, etaL. Common genetic varia- tion within IGFI,IGFII,IGFBP-I,and IGFBP-3 and endo- metrial cancer risk [J]. Gynecol Oncol, 2011,120 (2) : 174 - 178.
  • 7Zhang Z,Zhou D,Lai Y,et al. Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K/AKT and MAPK signaling pathways[J]. Cancer Lett, 2012,319( 1 ) : 89-97.
  • 8Mueck AO,Seeger H, Rabe T. Hormonal contraception and risk of endometrial cancer:a systematic review[J]. Endocr Relat Cancer, 2010,17 (4) : R263-271.
  • 9Oherty JA, Cushing-Haugen KL, Sahzman BS, et al. Long- term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer[J]. Am J Obstet Gynecol, 2007,197(2) : 139.
  • 10Villaviceneio A,Aguilar G,Argtiello G,et al. The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria[J]. Gynecol Oncol,2010,117 (1):96-102.

同被引文献42

  • 1马桂娥,刘平,雷华.超重和肥胖妇女血清脂联素、抵抗素与胰岛素抵抗间的关系研究[J].中国保健医学杂志,2010,12(6):449-451.
  • 2赵敬,薛凤霞,华绍芳,张丽志.胰岛素对子宫内膜癌细胞增殖和凋亡的影响[J].中华妇产科杂志,2007,42(10):696-700. 被引量:20
  • 3杨开选,王超.子宫内膜增生症的病因及相关因素[J].实用妇产科杂志,2007,23(11):645-647. 被引量:15
  • 4Rosato V,Zucchetto A,Bosetti C,et al.Metabolic syndrome and endometrial cancer risk[J].Ann Oncol,2011,22(4):884-889.
  • 5Plati E,Kouskouni E,Malamitsi-Puchner A,et al.Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation[J].Fetil Steril,2010,94(4):1451.
  • 6McTiernan A,Irwin M,Vongruenigen V.Weight,physical activity,diet,and prognosis in breast and gynecologic cancers[J].J Clin Oncol,2010,28(26):4074-4080.
  • 7Friedenreich CM,Biel RK,Lau DC,et al.Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer[J].Cancer Epidemiol Biomarkers Prev,2011,20(11):2384-2395.
  • 8Mulholland DJ,Kobayashi N,Ruscetti M,et al.Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells[J].Cancer Research,2012,72(7):1878-1889.
  • 9Hotamisligil GS,Shargill NS,Spiegelman BM.Adipose expression of tumor necrosis factor-alpha:direct role in obesitylinked insulin resistance[J].Science,1993,259(5091):87-91.
  • 10Jaiyeoba O,Lazenby C,Soper DE.Recommendations and rationale for the treatment of pelvic inflammatory disease[J].Expert Rev Anti Infect Ther,2011,9(1):61-67.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部